Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°£¼¼Æ÷¾Ï ¼ö¼ú ÈÄ Ç÷Áß ¾ËÆÄžƴܹéÀÇ ½ÇÁ¦¹Ý°¨±âÀÇ ÀÓ»óÀû À¯¿ë¼º Clinical Significance of the Actual Half-life of Serum Alpha-fetoprotein in Primary Hepatocellular Carcinoma

´ëÇÑ¿Ü°úÇÐȸÁö 2001³â 60±Ç 6È£ p.644 ~ 648
Á¤Ã¶¿î, ÃÖÁø¼·, ±èº´·Î,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤Ã¶¿î ( Chung Chul-Woon ) 
Æ÷õÁß¹®ÀÇ°ú´ëÇб³ ¿Ü°úÇб³½Ç

ÃÖÁø¼· ( Choi Jin-Sub ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±èº´·Î ( Kim Byong-Ro ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Abstract


Purpose
We observed the actual half life of the alpha- fetoprotein (AFP) had clinical meaning in that it reflected the long term prognosis more individually at a certain level of preoperative alpha-fetoprotein.
Methods
From preoperative and postoperative measurements of alpha-fetoprotein in 96 hepatocellular carcinomas the actual half lives were calculated with the formula: AHL T1/2 (days) = -0.3¡¿(T/log(C1/C0)), where T was the time interval between C1 and C0,
in
which C1 meant the level of AFP at postoperative 7 day, C0 the original AFP level. We investigated overall survival and disease free survival rate between delayed AHL group and non-delayed AHL group under various definitions of delay.
Results
The average actual half life of all cases was 5.1¡¾13.6 days. One, three and five year overall survival rates of the group with actual half life less than 4 days were 82.1%, 66.7%, 61.1% respectively, whereas those of the group with actual half
life
more than 4 days showed 83.0%, 36.5%, 18.2% respectively. The significance of different survival rates was much higher, when only the patients with preoperative alpha-fetoprotein above 100 ng/ml were taken into account (n=53, P=0.0019). The
disease
free
five year survival rates were also significantly different.
Conclusion
We can predict the elevated postoperative survival rate in the patients with actual half life of alpha- fetoprotein less than 4 days. And this has also relevant clinical meaning in the prognostication of disease free survival, if the preoperative
alpha-fetoprotein of patients has elevated up to over 100 ng/ml. The measurement of actual half life of postoperative hepatocellular carcinoma patients can be a clinical useful parameter for the prognosis of long term survival.

Å°¿öµå

¾ËÆÄžƴܹé; ½ÇÁ¦¹Ý°¨±â; °£¼¼Æ÷¾Ï; ¿¹ÈÄÀÎÀÚ; Alpha-fetoprotein; Actual half-life; Hepatocellular carcinoma; Prognosis;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS